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S U M M A R Y
Objectives: The deﬁnitive diagnosis of endobronchial tuberculosis (EBTB) is challenging because the
disease manifests in various non-speciﬁc ways, and acid-fast bacilli (AFB) are often undetectable by
sputum smear. The objective of this study was to evaluate the efﬁcacy of real-time PCR of bronchoscopic
biopsy specimens for the diagnosis of EBTB.
Methods: Real-time PCR ampliﬁcation of Mycobacterium tuberculosis DNA in biopsy tissue from EBTB
patients was performed prospectively. Diagnostic yields were compared for real-time PCR and for
auramine O-stained sputum smears and bronchial brush smears. Whether diagnostic yield depended on
bronchoscopic subtype of EBTB was also evaluated.
Results: Diagnostic yields were 4.1% (3/74) for sputum smear, 39.2% (29/74) for bronchial brush smear,
and 89.2% (66/74) for real-time PCR. Real-time PCR melting curve analysis showed signiﬁcantly higher
yields than did AFB staining of bronchial brush smears for granular and caseating EBTB (p < 0.01).
Conclusions: Real-time PCR detection of M. tuberculosis DNA in EBTB biopsy tissue is more sensitive than
sputum smear and bronchial brush smear, including at early disease stages. This PCR method may be a
useful adjunct to culture- and smear-based techniques to allow more rapid EBTB diagnosis and timelier
treatment.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Endobronchial tuberculosis (EBTB) is a less common and more
serious form of tuberculosis infection. The deﬁnitive diagnosis is
based on a positive stain for acid-fast bacilli (AFB) or the isolation
of Mycobacterium tuberculosis from respiratory secretions com-
bined with bronchoscopic examination.1 Diagnosing EBTB is
challenging because it manifests clinically and bronchoscopically
in a variety of non-distinctive ways, sometimes mimicking the
signs and symptoms of a range of diseases including asthma, lung
cancer, pneumonia, and bronchiectasis.2,3 In addition, patients
with EBTB often have negative results on testing for the presence of
AFB in sputum smears. The diagnostic yield is higher with
endobronchial biopsy than with endobronchial brushing,4,5 but
it is still only 72.2%.6 The identiﬁcation of M. tuberculosis in* Corresponding author.
E-mail address: qywang2002@hotmail.com (Q.-y. Wang).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).cultured specimens can take 6–8 weeks even when specimens are
in good condition.7 Since a delayed EBTB diagnosis can allow the
disease to progress to substantial ﬁbrostenosis and other
morbidities, even with occasional anti-tuberculosis chemothera-
py,2 early diagnosis is critical.
PCR allows the early diagnosis of tuberculosis with high
sensitivity and speciﬁcity. However, PCR shows only 53–73%
sensitivity in patients who are negative by sputum smear, although
its speciﬁcity is 88–98%.8,9 Real-time PCR has recently been
described as a means to lower the risk of contamination associated
with conventional PCR,10 as well as increase speed, robustness, and
reproducibility. However the diagnostic yield of real-time PCR for
detecting M. tuberculosis in bronchoscopic biopsy tissue is
unknown.
In the current study, we evaluated the diagnostic yields of real-
time PCR for detecting M. tuberculosis DNA in bronchoscopic biopsy
tissues in patients with different bronchoscopic subtypes of EBTB,
and we compared those yields with yields from AFB-stained
bronchoscopic brush smears.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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2.1. Subjects
This study was approved by the Institutional Ethics
Review Board of The First Afﬁliated Hospital, China Medical
University, Shenyang, China. A consecutive sample of patients at
our hospital who had not undergone any previous anti-
tuberculosis therapy and who were suspected of having EBTB
were enrolled in the study between April 2011 and October
2012. All patients gave written informed consent prior to
enrolment.
The diagnosis of EBTB was conﬁrmed by positive bronchoscopic
and histological examination and microbiological tests (tissue
culture for tuberculosis and/or AFB stain of bronchial brushings) in
accordance with the diagnostic criteria of the Chinese Thoracic
Society.11 As a control group, we enrolled consecutive patients
with biopsy-conﬁrmed lung cancer who were treated at our
hospital during the same period.
2.2. Tissue collection and processing
Sputum was collected from all patients. One experienced
pulmonologist used standard bronchoscopy (1T260, Olympus,
Japan) to take two bronchial brushings from the bronchial
segments where the EBTB lesion was located. Six bronchoscopic
biopsies were also taken from the site of the tracheobronchial
lesions, in the same segment; four were processed for
histopathology, one for tissue culture, and one for real-time
PCR.
Sputum smears and bronchoscopic brush smears were exam-
ined for the presence of AFB using the rapid auramine O ﬂuorescent
stain (‘AO stain’, Ourchem; Sinopharm Chemical Reagent Co. Ltd,
Shanghai, China).12 All biopsy samples were reviewed indepen-
dently by two senior pathologists; discrepant conclusions were
discussed until a consensus diagnosis was obtained. Based on
bronchoscopic manifestations, the EBTB of each patient was
classiﬁed into one of the following subtypes:11 caseating,
edematous–hyperemic, ﬁbrostenotic, granular, tumorous, and
ulcerative (Figure 1).Figure 1. Representative bronchoscopy images from patients in our sample with differen
(D) granular, (E) ulcerative, and (F) tumorous.2.3. DNA isolation
DNA from biopsies was extracted with the QIAamp DNA Mini
Kit (Qiagen, Hilden, Germany) in accordance with the manufac-
turer’s instructions. The DNA concentration was determined using
a Nanodrop spectrophotometer (Thermo Scientiﬁc, USA).
2.4. Real-time PCR
Real-time PCR of bronchoscopic biopsies was performed by a
technician blinded to the diagnosis. The following primer sets were
used (Takara Bio, Dalian, China):13 M. tuberculosis IS6110, 50-
TTGGAAAGGATGGGGTCA-30 (forward) and 50-CGCAGCCAACAC-
CAAGTAG-30 (reverse); and b-actin, 50-AGTTGCCTTACACCCTT-
TATTG-30 (forward) and 50-TCACCTTCACCGTTCCAGTTT-30
(reverse). The M. tuberculosis primers gave an amplicon of
156 bp; the b-actin primers gave an amplicon of 149 bp. Screening
experiments indicated that the optimal primer concentration was
0.4 mM (data not shown).
Real-time PCR was performed using the ABI PRISM 7500HT
Real-Time PCR System (Applied Biosystems, Foster City, CA, USA).
Thermal cycling conditions were as follows: initial denaturation at
95 8C for 1 min; ampliﬁcation for 40 cycles of 95 8C for 5 s and 60 8C
for 30 s; dissociation at 95 8C for 15 s, followed by extension at
60 8C for 1 min; and ﬁnally melting at 95 8C for 15 s. Each PCR
reaction (20 ml) contained the following: SYBR Premix Ex Taq II
(2, 10 ml; Takara, Shiga, Japan), forward primer (10 mM, 0.8 ml),
reverse primer (10 mM, 0.8 ml), ROX reference dye (50, 0.4 ml;
Takara, Shiga, Japan), DNA template (50 ng in 2.0 ml), and dH2O
(6.0 ml). Each reaction contained both primer pairs to amplify M.
tuberculosis and b-actin DNA sequences as a control for DNA
ampliﬁcation. Each sample was tested in triplicate.
The cycle threshold (Ct) value was determined as a measure of
the sensitivity of the RT-PCR assay. We compared the diagnostic
yields based on ﬁxed Ct values for which 35 and 40 were set as the
cut-off values. If the annealing temperature of the melting curve
generated using SDS software (version 2.0 a23; Applied Biosys-
tems, Foster City, CA, USA) was 88.9  0.1 8C, the ampliﬁcation was
judged to be positive and speciﬁc. All positive reactions were
subjected to 2% agarose gel electrophoresis with a 100-bp DNA laddert EBTB subtypes: (A) actively caseating, (B) edematous–hyperemic, (C) ﬁbrostenotic,
Table 1
Baseline characteristics of patients with EBTB and control patients with lung cancer
EBTB patients Control patients p-Value
Number 74 75
Male/female 2.89/1 0.56/1 <0.001
Age, years, mean  SD 42.74  17.13 56.23  10.04 0.005
Bronchoscopic classiﬁcation
of subtype, n







Small cell lung cancer - 23
Adenocarcinoma - 21
Squamous cell cancer - 19
Sarcoid cancer - 1
Large cell lung cancer - 1
Non-classiﬁed lung cancer - 10
EBTB, endobronchial tuberculosis; SD, standard deviation.
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speciﬁcity. In parallel, negative control PCR reactions were performed
using distilled water instead of template, and positive control
reactions were performed using a killed culture of M. tuberculosis
strain H37Rv (Figure 1).
2.5. Statistical analysis
The diagnostic sensitivities of the three methods were
compared using Chi-square tests and Fisher’s exact tests in SPSS
v. 17.0 (SPSS Inc., Chicago, IL, USA). Statistical signiﬁcance was set
at p < 0.05.
3. Results
3.1. Patient characteristics
A consecutive sample of 87 patients with suspected EBTB based
on computed tomography and bronchoscopic ﬁndings were
enrolled. Of these, 74 patients were diagnosed with EBTB by
tissue culture and were enrolled in the ﬁnal analysis (Table 1); theFigure 2. Melting curve analysis of real-time PCR for EBTB detection. In panel B, the left pe
white arrow) indicates a Mycobacterium tuberculosis-positive ampliﬁcation that the melti
(panel A, black arrow) indicates an ampliﬁcation reaction with cycle threshold = 35, whic
(panel B, black arrow).remaining 13 were diagnosed with lung cancer (n = 6), amyloidosis
(n = 2), and non-speciﬁc inﬂammation (n = 5). As a control group,
81 patients with suspected lung cancer based on computed
tomography and bronchoscopy were enrolled. Of these, 75 were
diagnosed with lung cancer and were enrolled in the ﬁnal analysis,
while the other six patients had amyloidosis (n = 1) or non-speciﬁc
inﬂammation (n = 5).
3.2. Diagnostic yields of real-time PCR of bronchial biopsies
The diagnostic performance of real-time PCR to detect EBTB in
bronchial biopsies was evaluated using melting curve analysis.
Ampliﬁcations for which the annealing temperature of the melting
curve was 88.9  0.1 8C were considered positive and speciﬁc,
regardless of the Ct value (Figures 2A and 2B). Based on this criterion,
sensitivity was 89.2%, speciﬁcity was 96.0%, the negative predictive
value was 90.0%, and the positive predictive value was 95.7%.
We also subjected all PCR reactions positive by melting curve
analysis to agarose gel electrophoresis in order to verify the
presence of the EBTB amplicon. Of the 66 samples analyzed, 63
(96%) were positive for the expected M. tuberculosis 156-bp band,
whereas the others did not show any bands except for the 149-bp
b-actin internal control (data not shown). Among the ﬁve samples
positive by melting curve analysis and with Ct values >35, two
(40%) showed the M. tuberculosis amplicon. All three samples that
were positive by melting curve analysis but negative by gel
electrophoresis had Ct values >35 (Figure 3). Thus melting curve
analysis of real-time PCR showed better sensitivity and accuracy
than using a Ct cut-off.
Finally we compared diagnostic yields using melting curve
analysis and using a ﬁxed Ct cut-off (Table 2). Sensitivity was
similar for melting curve analysis and for a cut-off of 40, but it was
lower for a cut-off of 35. Speciﬁcity was higher with melting curve
analysis than with a ﬁxed Ct cut-off. Therefore, subsequent
analysis to compare the diagnostic performance of real-time PCR
with that of smears was based on melting curve analysis.
3.3. Comparison of diagnostic yields with different techniques
Among the 74 patients with EBTB, only three (4.1%) were AFB-
positive by sputum smear, whereas 29 (39.2%) were AFB-positive
by bronchial brush smear. In contrast, 89.2% (66/74) were positiveak is the b-actin peak and the right peak is the IS6110 peak. The purple line (panel A,
ng curve analysis revealed to be a false-positive (panel B, white arrow). The blue line
h we interpreted as negative, but the melting curve analysis revealed it to be positive
Table 2
Performance of real-time PCR of bronchial biopsy tissue for EBTB diagnosis using
cycle threshold cut-off values or melting curve analysis
Result Ct cut-off Melting curve analysis
35 40
Total number of samples 149 149 149
True-positives, n 61 66 66
True-negatives, n 68 60 72
False-positives, n 7 15 3
False-negatives, n 13 8 8
Sensitivity, % 82.4 89.2 89.2
Speciﬁcity, % 90.7 80.0 96.0
NPV, % 84.0 88.2 90.0
PPV, % 89.7 81.5 95.7
EBTB, endobronchial tuberculosis; Ct, cycle threshold; NPV, negative predictive
value; PPV, positive predictive value.
Table 4
Comparison of diagnostic yields of AFB-stained bronchial brush smears with real-
time PCR melting curve analysis of bronchial biopsies by bronchoscopic subtype of
EBTB
Subtype Diagnostic yield, % (n/N) Chi-square p-Value
Smear PCR
Caseating 44.1 (15/34) 97.1 (33/34) 22.95 <0.001
Granular 46.2 (6/13) 92.3 (12/13) 6.50 0.030
Ulcerative 50 (3/6) 100 (6/6) 4.00 0.182
Edematous–hyperemic 22.2 (2/9) 77.8 (7/9) 5.56 0.057
Fibrostenotic 20 (2/10) 70 (7/10) 5.05 0.07
Tumorous 0 (0/2) 50 (1/2) –a –a
AFB, acid-fast bacilli; EBTB, endobronchial tuberculosis.
a This subtype was excluded from all comparisons because there were only two
patients with tumorous EBTB.
Figure 3. Reverse transcription PCR was performed using samples from bronchial
biopsy. Lane MM, size markers; lanes 1–9, EBTB samples processed by real-time PCR
(samples 1, 3, 7, and 8 had cycle threshold values >35); lane 9, positive control; lane
10, negative control.
G. Hou et al. / International Journal of Infectious Diseases 27 (2014) 13–1716by real-time PCR of bronchoscopic biopsy tissue based on melting
curve analysis. This diagnostic yield was much higher than that
observed with either smear technique (Chi-square = 109.87,
p < 0.001).
3.4. Dependence of diagnostic yield on bronchoscopic subtype of EBTB
Diagnostic yields of AFB staining of bronchial brush smears and
of real-time PCR of bronchial biopsies were compared for each
bronchoscopic subtype (Table 3). The tumorous subtype was not
examined because our sample contained only two cases. The
diagnostic yield of AFB staining of bronchial brush smears did not
vary signiﬁcantly with EBTB subtype (p > 0.05). The yield of real-
time PCR, however, did vary signiﬁcantly (Chi-square = 8.42,Table 3
Diagnostic yield of real-time PCR melting curve analysis by bronchoscopic EBTB
subtype
Subtype Yield, % (n/N) Chi-square p-Value
Caseating 97.1 (33/34) 8.42a 0.015a
Granular 92.3 (12/13)
Ulcerative 100 (6/6)
Edematous–hyperemic 77.8 (7/9) 5.11b 0.097b
Fibrostenotic 70 (7/10) 7.92c; 0.54d 0.025c; 0.650d
Tumorous 50 (1/2) –e –e
EBTB, endobronchial tuberculosis.
a Refers to the combined set of ulcerative, granular, and caseating subtypes.
b Comparison of edematous–hyperemic cases with the combined set of
ulcerative, granular, and caseating cases.
c Comparison of ﬁbrostenotic cases with the combined set of ulcerative, granular,
and caseating cases.
d Comparison of ﬁbrostenotic cases with edematous–hyperemic cases.
e This subtype was excluded from all comparisons because there were only two
patients with tumorous EBTB.p = 0.015; Table 3). Yield was signiﬁcantly higher for ulcerative,
granular, or caseating EBTB than for edematous–hyperemic or
ﬁbrostenotic disease. In this analysis, patients with ulcerative,
granular, or caseating types were combined because of the small
numbers of PCR-negative cases.
The diagnostic yield of real-time PCR of bronchial biopsies was
greater than that of AFB staining of bronchial brush smears in
patients with granular and caseating EBTB, but it was similar to the
yield of bronchial brush smears in patients with ulcerative or
ﬁbrostenotic EBTB (Table 4).
4. Discussion
EBTB is M. tuberculosis infection of the tracheobronchial tree
and accounts for 10–37% of pulmonary tuberculosis.12–14 The two
most important goals of EBTB treatment are to eradicate the
tubercle bacilli and prevent bronchostenosis as soon as possible,1
so sensitive and rapid diagnostic tools for EBTB are urgently
needed.
Sputum, although the easiest sample to obtain and the most
useful for culturing M. tuberculosis, shows diagnostic yields of
0–53% in EBTB.4,15,16 This is lower than the yield of sputum smears
for pulmonary tuberculosis in general, which ranges from 20% to
80%.10,17,18 Consistent with the low diagnostic yield of sputum
smears in EBTB, only 4.1% of our patients tested positive by this
technique. This low yield has been attributed to various causes,
including mucus entrapment by proximal granulation tissue,
natural recovery, and ﬁbrostenosis.10,19 When sputum smears are
negative, bronchoscopy is usually performed to obtain material for
bacteriological and histological examination. Bronchoscopic brush
smears have been reported to show sensitivities of 10–85% in
EBTB.16 In our study, the yield of AFB staining of bronchial brush
smears was 39.2%, which was higher than that of sputum smears,
but still unsatisfactory.
Conventional PCR can support the rapid diagnosis of tubercu-
losis, but it can easily give false-positives and negatives in the
absence of strict quality control.20 Real-time PCR, which is less
vulnerable to contamination,10,20 has been reported to have
sensitivities of 75–94% and speciﬁcities of 88–100% for tuberculo-
sis.21–23 In the present study we found that, in the case of EBTB,
real-time PCR melting curve analysis of bronchial biopsy tissues
had higher speciﬁcity and sensitivity than either sputum smears or
bronchial brush smears. We obtained a speciﬁcity of 96.0% using
real-time PCR melting curve analysis, consistent with the high
speciﬁcity reported for real-time PCR for tuberculosis in general.
Studies analyzing the diagnostic performance of real-time PCR
to detect tuberculosis have found no signiﬁcant differences with
different specimen types, including sputum, bronchial aspirates,
and bronchoalveolar lavage ﬂuid.24 In contrast, one study of the
diagnostic usefulness of PCR in tuberculosis found yield to depend
G. Hou et al. / International Journal of Infectious Diseases 27 (2014) 13–17 17on the type of specimen, with sputum giving the highest yield and
blood the lowest.25 The results mentioned above are very different
to ours, though none of the samples in that previous study involved
EBTB. We suggest that these different results are due primarily to
differences in mycobacterial load. Indeed, a study of real-time PCR
to diagnose tuberculosis in bronchoscopic biopsies found that real-
time PCR analysis of such biopsies gave higher sensitivity than
analyses of bronchial aspirates, bronchoalveolar lavage ﬂuid, or
sputum.24 This is similar to the results of the present study. They
found that sensitivity was quite low for samples from sterile
locations but it was higher for some non-liquid samples, such as
tissue (41.7%), lymph nodes (70.6%), and abscess aspirate
(76.5%).26 They attributed the higher sensitivity of the non-liquid
samples to the larger inoculum size (implying larger bacterial
load). EBTB tissues are usually looser and more easily sampled,
except in the case of ﬁbrostenotic EBTB. The bacterial load of
bronchial biopsy tissue is greater than that of sputum, bronchial
aspirates, and bronchial brush. Perhaps the same factors may
explain our observations regarding the diagnostic yield for
different sample types.
We found that the diagnostic yield of real-time PCR of biopsy
tissues depended on the EBTB subtype, whereas the yield of AFB
staining of bronchial brush smears did not. In our study, samples
from patients with ﬁbrostenotic EBTB showed the lowest yield,
while samples from patients with granular, ulcerative, or caseating
EBTB showed the highest. These results are consistent with those
of a study of the M. tuberculosis positivity of bronchoalveolar lavage
ﬂuid in EBTB patients.4 In that study, the highest rates of smear and
culture positivity were obtained with granular EBTB, while both
tests gave very low positive results for patients with ﬁbrostenotic
EBTB or non-speciﬁc bronchitis. Again, we speculate that
differences in the diagnostic yield of real-time PCR for different
bronchoscopic subtypes of EBTB may be due to differences in
bacterial load and its accessibility during sampling.
EBTB subtypes reﬂect different stages of disease progression.
Caseating, ulcerative, and granular subtypes occur early in disease,
while ﬁbrostenotic and edematous–hyperemic subtypes occur
later.27 Bronchial stenosis is inevitable if EBTB progresses beyond
the critical point from early stage to late stage, highlighting the
need for early-stage EBTB diagnosis. Our ﬁndings indicate that
real-time PCR gives signiﬁcantly higher diagnostic yield than AFB
staining of sputum smears or bronchial brush smears for the early
stages of caseating and granular EBTB. Thus real-time PCR may be a
particularly powerful tool for the early detection of EBTB. Real-
time PCR may be useful for the initial diagnosis and prompt
initiation of tuberculosis therapy, and then smear- or culture-
based approaches may be performed for deﬁnitive diagnosis and
the evaluation of drug resistance.
The present study has several limitations. First, it was a single-
center study with a relatively small patient sample. As a result, our
group included too few patients with tumorous EBTB to allow
subgroup analyses. Second, M. tuberculosis DNA real-time PCR
cannot distinguish between dead and live mycobacteria, empha-
sizing the need to combine our approach with other tools for
deﬁnitive diagnosis and management.
Our ﬁnding that real-time PCR of bronchoscopic biopsy tissue is
more sensitive than conventional sputum smears and broncho-
scopic brush smears for detecting M. tuberculosis lays the
groundwork for further optimization of real-time PCR as a rapid
and sensitive addition to available tools for diagnosing EBTB.
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